GlassScriptPhysician profile
Lawrence J Robinson
NPI 1336212448
$579.87
in general payments reported to CMS, 2019-2025
10 companies · $62.51 in 2025
The $62.51 reported for 2025 was less than what a typical Neurology (Psychiatry & Neurology) provider received nationally (typical 2025 total: $454).
See the full distribution for Neurology (Psychiatry & Neurology)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $44.64 · 2021: $86.10 · 2022: $190 · 2023: $197 · 2025: $62.51.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $241 · Education: $18.56.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $240.76 |
| Education | $18.56 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $281.50 | 2021-2025 | Ubrelvy, Qulipta, Botox |
| Teva Pharmaceuticals USA, INC. | $120.29 | 2022 | |
| Allergan, INC. | $39.10 | 2019-2021 | |
| Biohaven Pharmaceutical Holding Company LTD. | $26.05 | 2022 | |
| Ucb, INC. | $26.00 | 2022 | |
| Novartis Pharmaceuticals Corporation | $22.01 | 2019 | |
| Cadwell Industries, INC | $18.56 | 2023 | |
| Biohaven Pharmaceuticals, INC. | $17.29 | 2021 | |
| Genzyme Corporation | $15.63 | 2021 | |
| Pfizer INC. | $13.44 | 2023 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Lawrence Robinson listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.